Heterogeneity of nigral and cortical Lewy bodies differentiated by amplified triple-labeling for alpha-synuclein, ubiquitin, and thiazin red - PubMed (original) (raw)

Comparative Study

Heterogeneity of nigral and cortical Lewy bodies differentiated by amplified triple-labeling for alpha-synuclein, ubiquitin, and thiazin red

Masaki Sakamoto et al. Exp Neurol. 2002 Sep.

Abstract

Alpha-synuclein(alpha-S) and ubiquitin(Ub) are constituents of the Lewy bodies (LBs), composed of fibrillary structures. To clarify morphological heterogeneity of LBs, we looked for localization of these epitopes in relation to fibrillary structure possibly detectable by a fluorochrome, thiazin red (TR). On the sections of the substantia nigra (SN) and the cingulate gyrus (CG) obtained from Parkinson's disease brains, double amplification by CARD fluorescent immunohistochemistry with anti-alpha-S monoclonal (LB509) and anti-Ub polyclonal antibodies was performed, followed by staining with TR. These triple-labeled images were captured by a confocal laser microscope and subsequently stained with Campbell-Switzer method, a silver staining specific for LBs. Staining profiles of LBs were different between those in the SN and in the CG. Immunolabeling either with the anti-alpha-S or anti-Ub antibody was diffuse without halo structure in LBs of CG. In addition to this diffuse staining, a lot of LBs of SN exhibited a halo structure immunopositive for alpha-S and Ub, probably representing later stages of LB evolution. Irrespective of the presence of this halo structure, the TR signal was always concentrated in the center of LBs, as the silver-stained material was, suggesting that fibrillary components in the central portion of LBs undergo some conformational changes detectable by TR and the silver-staining. This technique reveals different epitopes in relation to LB evolution in vivo. Heterogeneity in staining profile of LBs, as clarified by this method, may represent evolutional changes of LBs, related to conformational states of their constituents.

PubMed Disclaimer

Cited by

Analysis of α-Synuclein Pathology in PINK1 Knockout Rat Brains.
Creed RB, Goldberg MS. Creed RB, et al. Front Neurosci. 2019 Jan 9;12:1034. doi: 10.3389/fnins.2018.01034. eCollection 2018. Front Neurosci. 2019. PMID: 30686993 Free PMC article.
Three-layered structure shared between Lewy bodies and lewy neurites-three-dimensional reconstruction of triple-labeled sections.
Kanazawa T, Uchihara T, Takahashi A, Nakamura A, Orimo S, Mizusawa H. Kanazawa T, et al. Brain Pathol. 2008 Jul;18(3):415-22. doi: 10.1111/j.1750-3639.2008.00140.x. Epub 2008 Apr 2. Brain Pathol. 2008. PMID: 18394008 Free PMC article.
Pale neurites, premature α-synuclein aggregates with centripetal extension from axon collaterals.
Kanazawa T, Adachi E, Orimo S, Nakamura A, Mizusawa H, Uchihara T. Kanazawa T, et al. Brain Pathol. 2012 Jan;22(1):67-78. doi: 10.1111/j.1750-3639.2011.00509.x. Epub 2011 Aug 16. Brain Pathol. 2012. PMID: 21672073 Free PMC article.
Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain.
Teil M, Dovero S, Bourdenx M, Arotcarena ML, Darricau M, Porras G, Thiolat ML, Trigo-Damas I, Perier C, Estrada C, Garcia-Carrillo N, Herrero MT, Vila M, Obeso JA, Bezard E, Dehay B. Teil M, et al. NPJ Parkinsons Dis. 2023 Sep 19;9(1):135. doi: 10.1038/s41531-023-00579-w. NPJ Parkinsons Dis. 2023. PMID: 37726343 Free PMC article.
The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration.
Mahul-Mellier AL, Burtscher J, Maharjan N, Weerens L, Croisier M, Kuttler F, Leleu M, Knott GW, Lashuel HA. Mahul-Mellier AL, et al. Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4971-4982. doi: 10.1073/pnas.1913904117. Epub 2020 Feb 19. Proc Natl Acad Sci U S A. 2020. PMID: 32075919 Free PMC article.

Heterogeneity of nigral and cortical Lewy bodies differentiated by amplified triple-labeling for alpha-synuclein, ubiquitin, and thiazin red - PubMed (original) (raw)